SomnoMed (ASX:SOM) is a public company providing diagnostic and treatment solutions for Sleep-related Breathing Disorders including obstructive sleep apnea, snoring and bruxism. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent(R) becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent(R) is the most comfortable and effective design and treatment solution for over 130,000 patients in 22 countries. For additional information, visit SomnoMed at http://www.somnomed.com.au
SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today its results for the first half year to December 2013. The company posted strong unit and revenue growth, generated profits and cash whilst continuing to invest in its future through its medical initiative and further acquisitions in both Europe and the APAC regions.
SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today the expansion of its business in the Republic of Korea, following the registration by the Korean FDA of SomnoDent(R) as an accepted medical device for the treatment of obstructive sleep apnea.
Australian Market Report of February 9, 2011 includes: SomnoMed Limited (ASX:SOM) announced that oral appliance treatment is now reimbursable for Medicare patients in the US; Padbury Mining Limited (ASX:PDY) discovered high-grade haematite mineralisation in Western Australia; Highlands Pacific Limited (ASX:HIG) today reports a 79% increase in resource tonnage at its Frieda Horse Ivaal Trukai project in Papua New Guinea; Zenith Minerals Limited (ASX:ZNC) announced results from Mount Alexander Magnetite Iron Project.
Somnomed Limited (ASX: SOM) - Acquisition of Swiss Bioplastic Venture & Quarterly Report - Dr Peter Neustadt, Executive Chairman; Somnomed Limited (ASX: SOM) present the following audio webcast regarding "Acquisition of Swiss Bioplastic Venture & Quarterly Report". You may also download this audio webcast to your computer or portable audio player.
SOMNOMED LIMITED (ASX: SOM) - Market Briefing - Mr John Truitt, CEO of North America; Boardroomradio is pleased to announce that SOMNOMED LIMITED (ASX: SOM) has published an audio file. The following
